Coherus Biosciences

Coherus Biosciences

Coherus Biosciences develops, manufactures and commercializes biologic therapeutics for oncology and inflammatory diseases. Learn more

Launch date
Employees
Market cap
€135m
Enterprise valuation
€236m (Public information from Sep 2024)
Redwood City California (HQ)
Authorizing premium user...